Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA-Reference-Cited by-同舟云学术

Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA

Published:2023-04-05 Issue:5 Volume:26 Page:437-444
ISSN:1369-7137
Container-title:Climacteric
language:en
Short-container-title:Climacteric

Author:

Sánchez-Borrego R.¹^ORCID,de Diego Pérez de Zabalza M. V.²,Alfageme Gullón M. J.³,Alija Castrillo M. L.⁴,Sánchez Prieto M.⁵^ORCID,Palacios S.⁶,González Calvo A. J.⁷,Quijano Martín J. J.⁷,Cancelo M. J.⁸

Affiliation:

1. Department of Obstetrics and Gynecology, Teknon Clinic, Barcelona, Spain

2. Department of Obstetrics and Gynecology, Quirón Pozuelo, Madrid, Spain

3. Department of Obstetrics and Gynecology, Hospital Quirón Torrevieja y Alicante, Alicante, Spain

4. Department of Obstetrics and Gynecology, HM San Francisco, León, Spain

5. Department of Obstetrics and Gynecology, Institut Universitari Dexeus, Barcelona, Spain

6. Department of Obstetrics and Gynecology, Palacios Institute of Women’s Health, Madrid, Spain

7. Medical Department, Shionogi S.L.U., Madrid, Spain

8. Department of Obstetrics and Gynecology, University Hospital of Guadalajara, Guadalajara, Spain

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13697137.2023.2190508

Reference39 articles.

1. Genitourinary syndrome of menopause

2. The effect of pathophysiological changes in the vaginal milieu on the signs and symptoms of genitourinary syndrome of menopause (GSM)

3. Association of Vaginal Microbiota With Signs and Symptoms of the Genitourinary Syndrome of Menopause Across Reproductive Stages

4. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women;Expert Opinion on Pharmacotherapy;2024-07-23

2. Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy;Maturitas;2024-05

3. Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials;Menopause;2024-04-23

4. Correction;Climacteric;2024-03-14

5. Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception;Gynecological Endocrinology;2023-10-09